Navigation Links
MiddleBrook Pharmaceuticals Reports Third Quarter 2007 Results
Date:11/14/2007

d, (8) receive required regulatory approvals, (9) successfully conduct clinical trials in a timely manner, (10) establish its competitive position for its products, (11) develop and commercialize products that are superior to existing or newly developed competitor products, (12) develop products without any defects, (13) have sufficient capital resources to fund its operations, (14) protect its intellectual property rights and patents, (15) implement its sales and marketing strategy, (16) successfully attract and retain collaborative partners, (17) successfully commercialize and gain market acceptance for its Keflex products, (18) successfully obtain sufficient manufactured quantities of its drug products at acceptable rates, and (19) retain its senior management and other personnel. Existing and prospective investors are cautioned not to place undue reliance on these forward-looking statements, which speak only as of today's date. MiddleBrook undertakes no obligation to update or revise the information in this announcement, whether as a result of new information, future events or circumstances or otherwise.

MIDDLEBROOK PHARMACEUTICALS, INC.

CONDENSED STATEMENTS OF OPERATIONS

(Unaudited)

Three Months Ended Sept 30, Nine Months Ended Sept 30,

2007 2006 2007 2006

Product sales $3,144,532 $2,369,975 $7,598,127 $3,566,563

Costs and

expenses:

Cost of product

sales 1,183,772 440,159 1,864,643 517,765

Research and

development 5,509,093 5,737,047 18,485,164 19,700,263

Selling, general

and administrative 6,475,742 6,069,529 20,473,947 13,001,312

Total

expenses 13,168,607 12,246,735 40,823,754 33,219,340

Loss from

opera
'/>"/>

SOURCE MiddleBrook Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine news :

1. MiddleBrook Pharmaceuticals Raises Up to $10 Million from Deerfield Management
2. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
3. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
4. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
5. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
6. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
7. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
8. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
9. Amylin Pharmaceuticals to Webcast Corporate Overview During 43rd Annual Meeting of the European Association for the Study of Diabetes
10. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
11. Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/30/2014)... by NIH grantees predicts that women must take the ... vaginal sex, whereas just two doses per week can ... finding helps explain why two large clinical trials testing ... show efficacy. Participants in the VOICE and ... antiretroviral) for HIV prevention were counseled to take one ...
(Date:10/30/2014)... Pompano Beach, Florida (PRWEB) October 30, 2014 ... surprise Halloween visit to Pompano Beach firefighters, showing that ... your community. , Timothy met firefighters Tracey and ... sponsored by Galuppi’s Restaurant and the Pompano Beach Chamber ... and outside the fire truck, letting Timothy wear his ...
(Date:10/30/2014)... NC (PRWEB) October 30, 2014 Don ... commercial, and health insurance plans for North Carolina residents, ... satellite office in Burlington’s Holly Hill Mall. The new ... with agents already helping customers through all facets of ... purchase. , Allred Insurance spokesman Scott Allred couldn’t be ...
(Date:10/30/2014)... 2014 Five months after their expansion, ... LLC announces new branding and a website to accompany ... After David Mepham’s promotion to name partner earlier this ... to include Mepham’s name and better reflect their combined ... firm, the decision to implement new branding reflects Hodgkinson ...
(Date:10/30/2014)... 30, 2014 Paramount Rx, a full-service ... increasing efforts to help people save money through its ... increase for prescription drugs in the new health care ... resources to bridge the relationship between consumers, businesses and ... biggest challenges people face today with medical costs is ...
Breaking Medicine News(10 mins):Health News:Model by NIH grantees explains why HIV prevention dosing differs by sex 2Health News:4-year-old InstaKNOT CEO Honors Local Firefighters with Community Support 2Health News:4-year-old InstaKNOT CEO Honors Local Firefighters with Community Support 3Health News:4-year-old InstaKNOT CEO Honors Local Firefighters with Community Support 4Health News:Allred Insurance Satellite Office Grand Opening 2Health News:Hodgkinson Street Mepham Rebrands 2Health News:Paramount Rx Discount Card Program Provides Valuable Resources in Midst of Current Health Care Reform 2Health News:Paramount Rx Discount Card Program Provides Valuable Resources in Midst of Current Health Care Reform 3
... Discussion focuses on innovative programs, partnerships, and ... intergenerational mentoring in the workplace, WOONSOCKET, ... developing innovative workforce programs to recruit and retain,employees, was ... Aging,in America Conference in Washington, D.C. for a discussion ...
... Cardiology ... - FDA appeal progressing, TORONTO, March 28 /PRNewswire-FirstCall/ ... audited financial results,for the year ended December 31, 2007., "During ... and CEO. We made tremendous progress on,several fronts, including a License, ...
... The Pennsylvania,Health Care Cost Containment Council (PHC4) announced ... stepping down as head of the,innovative health care agency. ... his last day of employment has not yet been ... became Executive Director in,1998., "Marc has been a ...
... is Professor Patrick Tam from the Childrens Medical Research Institute, ... the Australian Academy of Science. , Peter Doherty, Ian Frazer ... have been honoured by election to the academy. Professor Tam ... , Professor Tam and his team have recently completed a ...
... NEW YORK, March 28 /Xinhua-PRNewswire-FirstCall/ -- China ... "Company") a leading,provider in the nutraceutical industry ... organic nutritional food products,supplements, and personal care ... in the final stages of the acquisition ...
... WELLINGTON, Fla., March 28 The Quantum ... announced today that,the Board of Directors and Noel ... have reached an agreement to amend his existing,employment ... of employment,with the Company. The terms of the ...
Cached Medicine News:Health News:CVS Caremark Presents at NCOA-ASA Conference on Company's Commitment to Recruiting and Retaining Mature Workers 2Health News:CVS Caremark Presents at NCOA-ASA Conference on Company's Commitment to Recruiting and Retaining Mature Workers 3Health News:PreMD Reports Fiscal 2007 Results 2Health News:PreMD Reports Fiscal 2007 Results 3Health News:PreMD Reports Fiscal 2007 Results 4Health News:PreMD Reports Fiscal 2007 Results 5Health News:PreMD Reports Fiscal 2007 Results 6Health News:PreMD Reports Fiscal 2007 Results 7Health News:PreMD Reports Fiscal 2007 Results 8Health News:PreMD Reports Fiscal 2007 Results 9Health News:PreMD Reports Fiscal 2007 Results 10Health News:PreMD Reports Fiscal 2007 Results 11Health News:PreMD Reports Fiscal 2007 Results 12Health News:National recognition for top scientist 2Health News:China Yingxia International Announces Soybean Milk Production Lines Acquisition 2Health News:The Quantum Group Extends CEO's Employment Agreement 2Health News:The Quantum Group Extends CEO's Employment Agreement 3
(Date:10/30/2014)... , Oct. 29, 2014 The global ... 2013 with the introduction of new vaccines. These ... Vaccines: The World Market. The Kalorama information report ... commercialized vaccines and developmental vaccines for diseases that ... individuals, but also entire communities from diseases spread ...
(Date:10/27/2014)... , Oct. 27, 2014  RenovoRx, a leading ... flow and delivery of fluids to selected sites in ... of Directors has appointed Shaun Bagai as ... the RenovoRx Board of Directors. Bagai brings more than ... Bagai joined RenovoRx in June 2014 and ...
(Date:10/27/2014)... the last few weeks, Ebola has gone from a localized health ... worldwide crisis when a traveler to United States ... were infected. While much of the cable news talk ... such as electronic health records (EHRs), to help find, combat, and ... Editor Alison Diana fills in those gaps by explaining ...
Breaking Medicine Technology:Vaccines 2014: World Market Analysis, Key Players, Trends, Pediatric and Adult Segments 2Vaccines 2014: World Market Analysis, Key Players, Trends, Pediatric and Adult Segments 3RenovoRx Board Names Shaun R. Bagai as CEO 2EHRs in the Age of Ebola: Discuss on InformationWeek 2EHRs in the Age of Ebola: Discuss on InformationWeek 3
... 5 Express Scripts (Nasdaq: ESRX ) ... unit to create a new independent, nonprofit charitable organization ... for low-income, uninsured Americans and working families. ... Scripts, leads the new national organization, which has its ...
... Pittsburgh is redistributing its 196 beds to include a third ... broaden its service capabilities and better meet the needs of ... currently operates two locations: the Main Campus at 225 Penn ... Allegheny General Hospital Suburban Campus at 100 South Jackson Avenue. ...
Cached Medicine Technology:Express Scripts Completes Spinoff of Rx Outreach 2LifeCare Hospitals of Pittsburgh Opening Third Location 2
Endoscopes are also available in fully autoclavable models in 1.8, 2.7, 4.0. 5.0 and 10.0 mm diameters. Manufactured with precise swiss lenses. Built-in temperature measuring device to exactly determ...
Cottle Tenaculum Skin Hook. 5 1/2" small, shallow curve....
Goldman single hook....
Needle tip electrode, davol advantage electrosurgical attachments, 33cm (with extendible outer sheath), non-sterile. These products are supplied non-sterile and must be sterilized before use. Reusabl...
Medicine Products: